<DOC>
	<DOC>NCT01185418</DOC>
	<brief_summary>The aim of the study is to investigate the negative symptoms and cognitive function after administration of antipsychotics in healthy volunteer.</brief_summary>
	<brief_title>Evaluation of Negative Symptoms and Cognitive Function After Administration of Antipsychotics in Healthy Volunteer</brief_title>
	<detailed_description />
	<mesh_term>Haloperidol</mesh_term>
	<mesh_term>Haloperidol decanoate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Aged 1838 years and meet no DSMIV diagnostic criteria as assessed by using the Structured Clinical Interview for DSMIV, research version. 1) anyone who participated in other clinical trials within 30 days from the start of this clinical trial or is currently participating in one, 2) anyone who has progressive disease or in unstable medical condition unfit for the trial, 3) anyone who has been diagnosed in psychiatric terms in the past, depends on psychotropic substance, or has overdosed or depended on the substance or alcohol (except for coffee or tobacco) within 1 month from the trial start, 4) anyone who is suicidal or highly probable of suicides, or 5) anyone who has test results considered clinically meaningful</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>38 Years</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>